Merger activity decreased with four new deals announced and two deals closing.
Deal Statistics:
New Deals:
- The acquisition of Diplomat Pharmacy (DPLO) by OptumRx for $300 million or $4.00 per share in cash.
- The acquisition of Synthorx (THOR) by Sanofi (SNY) for $2.35 billion or $68.00 per share in cash.
- The acquisition of ArQule (ARQL) by Merck & Co. (MRK) for $2.5 billion or $20.00 per share in cash.
- The merger of Texas Capital Bancshares (TCBI) and Independent Bank Group (IBTX) for approximately $3 billion in an all-stock deal. Under the terms of the merger